$11.66+0.77 (+7.07%)
Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. in the Healthcare sector is trading at $11.66 with a market capitalization of $1.1B. Wall Street consensus targets $17.67 (9 analysts), implying a +51.5% move over the next 12 months. The stock is currently 40% below its 52-week high of $19.45, remaining 3.9% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $264.16Mβ | $252.54Mβ | $267.73Mβ | $258.94Mβ | $251.40M |
| Gross Profit | $38.88Mβ | $34.78Mβ | $42.12Mβ | $39.71Mβ | $39.14M |
| Operating Income | $4.40Mβ | $4.53Mβ | -$7.47Mβ | $12.97Mβ | $11.17M |
| Net Income | $2.75Mβ | $1.72Mβ | -$28.69Mβ | -$3.50Mβ | -$7.23M |
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomog...